MedPath

长春长红制药有限公司

Ownership
-
Established
1982-02-22
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

16

NMPA:16

Drug Approvals

Diazepam Tablets

Product Name
地西泮片
Approval Number
国药准字H22021994
Approval Date
Aug 21, 2020
NMPA

Liquor Mercurochromi

Product Name
汞溴红溶液
Approval Number
国药准字H22026507
Approval Date
Oct 19, 2015
NMPA

Methylrosanilnium Chloride Solution

Product Name
甲紫溶液
Approval Number
国药准字H22022038
Approval Date
Oct 19, 2015
NMPA

Chlormezanone Tablets

Product Name
氯美扎酮片
Approval Number
国药准字H22024201
Approval Date
Sep 25, 2015
NMPA

BerberineHydrochlorideTablets

Product Name
盐酸小檗碱片
Approval Number
国药准字H22021887
Approval Date
Apr 21, 2014
NMPA

VitaminB2Tablets

Product Name
维生素B2片
Approval Number
国药准字H22022003
Approval Date
Apr 21, 2014
NMPA

EthambutolHydrochlorideTablets

Product Name
盐酸乙胺丁醇片
Approval Number
国药准字H22022006
Approval Date
Apr 21, 2014
NMPA

HydrogenPeroxideSolution

Product Name
过氧化氢溶液
Approval Number
国药准字H22021880
Approval Date
Apr 21, 2014
NMPA

水杨酸苯甲酸松油搽剂

Approval Number
国药准字H22026186
Approval Date
Apr 21, 2014
NMPA

CimetidineTablets

Product Name
西咪替丁片
Approval Number
国药准字H22022005
Approval Date
Apr 21, 2014
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.